Insteel Industries (IIIN) Q4 2025 earnings summary

Executive summary

• Fourth quarter net earnings rose to $14.6 million ($0.74 per diluted share), up from $4.7 million ($0.24 per share) year-over-year, driven by improved price-cost spreads, higher shipments, and strong non-residential demand.

• Fiscal 2025 net earnings reached $41.0 million ($2.10 per diluted share), compared to $19.3 million ($0.99 per share) in the prior year, despite $2.6 million in restructuring and acquisition-related costs.

• Operations focus on manufacturing and marketing steel wire reinforcing products for concrete construction, with 11 U.S. facilities and national market leadership in WWR and PC strand.

• Recent acquisitions performed well, with successful integration and positive financial contributions, expanding shipment volumes and market position.

• Strategy centers on market leadership, lowest cost production, and growth via organic initiatives and acquisitions.

Financial highlights

• Net sales for 2025 reached $826.8 million, up from $647.7 million in 2024 and $649.2 million in 2023.

• Gross profit for 2025 was $93.4 million (14.4% margin), up from $49.6 million (9.4% margin) in 2024.

• EBITDA for 2025 was $76.3 million (11.8% margin), compared to $38.5 million (7.3% margin) in 2024.

• Ended fiscal year with $38.6 million in cash and no debt.

• Operating activities generated $27.2 million in cash for fiscal 2025, down from $58.2 million, due to changes in net working capital.

Outlook and guidance

• Entering fiscal 2026 with solid momentum from operational improvements, improved raw material availability, and recent acquisitions.

• Public nonresidential construction expected to remain strong, supported by federal infrastructure investment.

• Management remains cautiously optimistic for 2026, focusing on operational execution, expense management, and targeted growth.

• Capital expenditures projected at up to $20 million for 2026, focused on plant, IT infrastructure, productivity, and maintenance.

• Inventory levels expected to remain elevated through Q2 2026 before normalizing.